home / stock / pbd / pbd news

PBD News and Press, Invesco Global Clean Energy From 09/08/20

Stock Information
Company Name: Invesco Global Clean Energy
Stock Symbol: PBD
Market: NYSE
Menu
PBD PBD Quote PBD Short PBD News PBD Articles PBD Message Board
Get PBD Alerts

News, Short Squeeze, Breakout and More Instantly...
PBD - Protalix BioTherapeutics Regains Compliance with NYSE American Continued Listing Standards

CARMIEL, Israel , Sept. 8, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant...
PBD - Protalix BioTherapeutics to Present in the H.C. Wainwright 22nd Annual Global Investment Virtual Conference

CARMIEL, Israel , Sept. 8, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant...

PBD - Renewable Energy Is Set For Exponential Growth In The Years Ahead

Investment Thesis It isn't your grandfather's energy landscape anymore. You know, the environment in which almost all energy consumption comes from fossil fuels like coal, petroleum, and natural gas, and any power generated by renewable sources had to be heavily subsidized by the governme...

PBD - Protalix BioTherapeutics Announces Completion of the Treatment Period for its Phase III BRIGHT Clinical Trial of Pegunigalsidase Alfa (PRX-102) for the Proposed Treatment of Fabry Disease

CARMIEL, Israel ,, Aug. 24, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® pla...
PBD - Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce U.S. Food and Drug Administration Acceptance of Biologics License Application (BLA) for Pegunigalsidase Alfa for the Proposed Treatment of Fabry Disease and Grants Priority Review

CARMIEL, Israel , Aug. 11, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant...

PBD - Protalix BioTherapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update

CARMIEL, Israel , Aug. 10, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® ...

PBD - Protalix BioTherapeutics to Present at the BTIG Virtual Biotechnology Conference 2020

CARMIEL, Israel , Aug. 6, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® p...
PBD - Protalix BioTherapeutics to Hold Second Quarter 2020 Financial Results and Business Update Conference Call on August 10, 2020

CARMIEL, Israel , Aug. 3, 2020 /PRNewswire/Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant cell...

PBD - Protalix BioTherapeutics Enters into Non-Binding Term Sheet with SarcoMed USA to Develop alidornase alfa for the Treatment of Pulmonary Sarcoidosis and Related Diseases

CARMIEL, Israel , July 23, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® ...

PBD - Some clean energy ETFs shine in brutal first half for fossil fuels

The energy sector is the worst performing stock market sector in the first half, with plunging oil prices and consumer demand alongside heavy debt loads among the driving factors. More news on: Energy Select Sector SPDR ETF, Invesco Exchange-Traded Fund Trust - Invesco Dynamic Oil & Ga...
Previous 10 Next 10